BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19425502)

  • 1. [Colorectal cancer 2D-proteomics: identification of altered protein expression].
    Krasnov GS; Oparina NIu; Khankin SL; Mashkova TD; Ershov AN; Zatsepina OG; Karpov VL; Beresten' SF
    Mol Biol (Mosk); 2009; 43(2):348-56. PubMed ID: 19425502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer.
    Rho JH; Qin S; Wang JY; Roehrl MH
    J Proteome Res; 2008 Jul; 7(7):2959-72. PubMed ID: 18549262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Analysis of Stage-II Breast Cancer from Formalin-Fixed Paraffin-Embedded Tissues.
    Abdullah Al-Dhabi N; Srigopalram S; Ilavenil S; Kim YO; Agastian P; Baaru R; Balamurugan K; Choi KC; Valan Arasu M
    Biomed Res Int; 2016; 2016():3071013. PubMed ID: 27110560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
    Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis.
    Kume H; Muraoka S; Kuga T; Adachi J; Narumi R; Watanabe S; Kuwano M; Kodera Y; Matsushita K; Fukuoka J; Masuda T; Ishihama Y; Matsubara H; Nomura F; Tomonaga T
    Mol Cell Proteomics; 2014 Jun; 13(6):1471-84. PubMed ID: 24687888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of proteins overexpressed in malignant gastric tumors: comparison of the results of 2-De and bioinformatics search].
    Grigor'eva ES; Bukurova IuA; Krasnov GS; Afanas'ev SG; Cherdyntseva NV; Tuzikov SA; Choĭnzonov EL; Karpov VL; Lisitsyn NA; Beresten' SF
    Mol Biol (Mosk); 2011; 45(4):738-43. PubMed ID: 21954607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and verification of gelsolin as a potential biomarker of colorectal adenocarcinoma in the Chinese population: Examining differential protein expression using an iTRAQ labelling-based proteomics approach.
    Fan NJ; Gao CF; Wang CS; Lv JJ; Zhao G; Sheng XH; Wang XL; Li DH; Liu QY; Yin J
    Can J Gastroenterol; 2012 Jan; 26(1):41-7. PubMed ID: 22288069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Label-free quantitative mass spectrometry reveals a panel of differentially expressed proteins in colorectal cancer.
    Fan NJ; Gao JL; Liu Y; Song W; Zhang ZY; Gao CF
    Biomed Res Int; 2015; 2015():365068. PubMed ID: 25699276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis.
    Sethi MK; Thaysen-Andersen M; Kim H; Park CK; Baker MS; Packer NH; Paik YK; Hancock WS; Fanayan S
    J Proteomics; 2015 Aug; 126():54-67. PubMed ID: 26054784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined miRNA profiling and proteomics demonstrates that different miRNAs target a common set of proteins to promote colorectal cancer metastasis.
    Torres S; Garcia-Palmero I; Bartolomé RA; Fernandez-Aceñero MJ; Molina E; Calviño E; Segura MF; Casal JI
    J Pathol; 2017 May; 242(1):39-51. PubMed ID: 28054337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer.
    Ludvigsen M; Thorlacius-Ussing L; Vorum H; Moyer MP; Stender MT; Thorlacius-Ussing O; Honoré B
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma.
    Kim CY; Jung WY; Lee HJ; Kim HK; Kim A; Shin BK
    Oncol Rep; 2012 Mar; 27(3):608-20. PubMed ID: 22076435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.
    Ma Y; Peng J; Liu W; Zhang P; Huang L; Gao B; Shen T; Zhou Y; Chen H; Chu Z; Zhang M; Qin H
    Mol Cell Proteomics; 2009 Aug; 8(8):1878-90. PubMed ID: 19460759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of collagen proteins in colorectal liver metastasis compared with normal liver tissue.
    van Huizen NA; Coebergh van den Braak RRJ; Doukas M; Dekker LJM; IJzermans JNM; Luider TM
    J Biol Chem; 2019 Jan; 294(1):281-289. PubMed ID: 30409905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases.
    Yang Q; Bavi P; Wang JY; Roehrl MH
    J Proteomics; 2017 Sep; 168():53-65. PubMed ID: 28669815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed proteins in retinoblastoma tumors using mass spectrometry-based comparative proteomic approach.
    Naru J; Aggarwal R; Mohanty AK; Singh U; Bansal D; Kakkar N; Agnihotri N
    J Proteomics; 2017 Apr; 159():77-91. PubMed ID: 28232133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative proteomic analysis of fibrosarcoma and skin fibroblast cell lines.
    Meral O; Uysal H
    Tumour Biol; 2015 Feb; 36(2):561-7. PubMed ID: 25270740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-surface markers for colon adenoma and adenocarcinoma.
    Sewda K; Coppola D; Enkemann S; Yue B; Kim J; Lopez AS; Wojtkowiak JW; Stark VE; Morse B; Shibata D; Vignesh S; Morse DL
    Oncotarget; 2016 Apr; 7(14):17773-89. PubMed ID: 26894861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.